City

New Haven (1)

San Francisco (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

n/a (2)

Sponsor

Harvard School of Public Health (HSPH) (1)

University of California, San Francisco (1)

Yale University (1)

Collaborator

National Cancer Institute (NCI) (1)

National Institute of Environmental Health Sciences (NIEHS) (1)

National Institutes of Health (NIH) (1)

Intervention

dietary intake (1)

measurements to evaluate metabolic bone disease (1)

standard care (1)

whole exome sequencing (wes) (1)

Study Documents

Intervention Type

device (1)

diagnostic test (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

skeletal anomalies

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Structural Anomalies, Cardiac Anomalies, CNS Anomalies Trial in San Francisco (Whole Exome Sequencing (WES))

Completed

Structural Anomalies
+7 more

Whole Exome Sequencing (WES)

San Francisco, California

University of California San Francisco

Jun 14, 2022

(Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal

Active, not recruiting

Cardiovascular Diseases
+8 more

Dietary intake

(no location specified)

Feb 28, 2022

Skeletal Anomalies, Kidney Transplant; Complications Trial in New Haven (measurements to evaluate metabolic bone disease,

Recruiting

Skeletal Anomalies
Kidney Transplant; Complications

measurements to evaluate metabolic bone disease
standard care

New Haven, Connecticut

Yale Transplantation Center/Yale-New Haven Hospital

Dec 16, 2021